Genasys enters amended cooperation agreement with Nicoya Capital, nominates five directors for 2026

Genasys Inc.

Nicoya Capital (affiliate of director Malhotra) extends standstill; Genasys nominates Danforth, Dodd, Fugate, Malhotra, Schmeiser for 2026 board.
Mark Culhane will not stand for re-election, remains Audit Committee chair until 2026 annual meeting.
Parties to seek mutually acceptable Audit Committee chair; Malhotra interim if none found before June 30, 2026.
Genasys repaid $4M additional term loan on Dec 29, 2025; $15M term loan remains outstanding.
Osgood and Culhane to serve on strategic advisory committee after 2026 annual meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.